期刊文献+

晚期非小细胞肺癌中医证候分布及动态演变临床研究 被引量:26

Clinical Study of the Distribution and Dynamic Evolution of Traditional Chinese Medicine Syndromes for Advanced Non-Small-Cell Lung Cancer
下载PDF
导出
摘要 目的:观察晚期非小细胞肺癌中医证候的分布及动态演变。方法:采用前瞻性流行病研究方法,对初次治疗的晚期非小细胞肺癌在病情发展的7个不同时点(治疗前,治疗后42 d、84 d、150 d、270 d、390 d及510 d)进行动态的证候观察。结果:各时点共出现20种不同的的中医辨证分型。证候要素研究方面,气虚证素治疗后42 d、84 d、390 d、510 d与治疗前比较,具有显著差异(P<0.05);阴虚证素、痰湿证素、血瘀证素治疗后510 d与治疗前比较,具有显著差异(P<0.05);在虚实证候研究方面,实证、虚实夹杂证治疗后42 d、84 d、390 d、510 d与治疗前比较,差异具有统计学意义(P<0.05)。结论:晚期非小细胞肺癌中医证候随着病程的推移,单证逐渐减少,复证逐渐增加。虚证、实证呈减少的趋势,而虚实夹杂证则逐渐增多。证侯要素中气虚、阴虚、痰湿及血瘀等均呈现增加的趋势。 Objective:To observe the distribution and dynamic evolution of traditional Chinese medicine(TCM) syndromes for advanced non-small-cell lung cancer(NSCLC). Methods:Prospective epidemiological methodology was adopted to observe the dynamic syndromes of the initial NSCLC treatment at seven different time points(before the treatment,and at 42,84,150,270,390 and 510 days after treat- ment). Results:There were a total of 20 different TCM syndroms at different time points. In terms of syndrome elements, in the patients with Qi deficiency syndrome, compare the curative effect with before and after the treatment (42 d, 84 d, 390 d,510 d), there was a sig- nificant difference(P 〈0.05). in the patients with Yin deficency syndrom, phlegm-damp syndrom and syndrome of blood stasis, com- pare the curative effect with before and after the treatment (510 d), there was a significant difference (P 〈 0.05 ). In terms of excess and deficiency, in the patients with syndrome of intermingled deficiency and excess, compare the curative effect with before and after the treatment(42 d,84 d,390 d,510 d) ,The difference is statistically significant. Conclusion:With the development of advanced NSCLC, single syndrome gradually declined and multiple syndromes increased. Deficiency syndromes and excess syndromes showed adecreasing, while the syndrome of intermingled deficiency and excess increased. Qi deficiency, Yin deficiency, phlegm-damp syndrom and syndrome of blood stasis were also on the increase as disease progressed.
出处 《中医学报》 CAS 2015年第8期1085-1088,共4页 Acta Chinese Medicine
基金 国家十一五科技支撑计划资助项目(2006BAI11B01-01 2006BAI04A05)
关键词 非小细胞肺癌 证候分布 证候演变 non-small-cell lung cancer distribution of syndromes evolution of syndromes
  • 相关文献

参考文献19

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 2Yang L,Parkin DM,Ferlay J,et al.Estimates of cancer incidence in China for 2000 and projections for 2005[J].Cancer Epidemiol Biomarkers,Prev,2005,14(1):243-250.
  • 3Wakelee H,Belani CP.Optimizing first-line treatment options for patients with advanced NSCLC[J].Oncologist,2005,10(3):1-10.
  • 4Maneqold C.Chemotherapy for advanced non-small-cell lung cancer[J].Lung Cancer,2001,34(Suppl 2):165-170.
  • 5傅军,俞杰,徐宏彬,李玲.中医药辅助实体肿瘤化疗增效减毒的系统性评价[J].中医药导报,2010,16(10):108-112. 被引量:10
  • 6Lin HS,Liu J,Zhang Y.Developments in the cancer prevention and treatment using traditional Chinese medicine[J].Front Med,2011,5(2):127-133.
  • 7陈衍智,邸立军,张淑兰,陈茂森,孙红,高飞,张莹,李萍萍.中药结合长春瑞滨加顺铂化疗治疗晚期非小细胞肺癌的多中心随机对照临床研究[J].中国肺癌杂志,2008,11(3):441-444. 被引量:10
  • 8Berle CA,Cobbin D,Smith N,et al.A novel approach to evaluate traditional Chinese medicine treatment outcomes using pattern identification[J].J Altern Complement Med,2010,16(4):357-367.
  • 9Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
  • 10Fossella F,Pereira JR,von Pawel J,et al.Randomized,multinational,phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group[J].J Clin Oncol,2003,21(16):3016-3024.

二级参考文献101

共引文献295

同被引文献441

引证文献26

二级引证文献196

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部